VELscope Guided Oral Cancer Surgery
Determine appropriate surgical margin more accurately in a real-time and increase your patient survival rate reducing recurrence up to 90%
More accurate Surgical Margin in Real-Time Assessment
VELscope Vx enhances the visibility of diseased tissue around a clinically-apparent lesion in real-time and helps to determine the appropriate surgical margin more accurately.
Result: Reduce oral cancer recurrence up to 90%
Instant Benefits for Doctors & Patients
- Reduce oral cancer recurrence up to 90%
- WHO recommended & FDA approved
- Real-time Assessment
- More effective than intraoperative FS
- Improved workflow – saved surgery time
- Evidence-based & Photo Documentation
- High success rate – satisfied patients
- Early diagnosis & Early treatment
- Painless follow-up
Dr. Pushkar P. Waknis From Operation Room
5 Reasons To Start Using VELscope Vx
1. Better oral cancer surgery outcomes
The tumor border is not clearly visible in white light to a naked eye. Sometimes it’s not apparent at all. Furthermore, diseased tissue often exceeds clinically apparent lesion and research have proved that oral cancer extension is not uniform around the cancerous area. So standard uniform margin around the tumor site may not always work causing not complete removal of cancerous cells. Such failure of a surgery may can cause cancer recurrence.
Meanwhile VELscope Guided Surgery enhances visibility of tumor border, so complete diseased tissue can be removed successfully. As a result, the risk of cancer coming back after surgery is reduced up to 90%.
2. Easy to use technology
The VELscope handheld device emits a harmless, bright blue light which enhances visualization of abnormal area, so tumor border can be seen clearly. Healthy tissue reflects blue light and appears as green, while diseased tissue absorbs blue light and appears dark, showing loss of fluorescence.
VELscope Vx is the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the appropriate margin for surgical excision.
3. More effective than Frozen Section (FS)
Intraoperative Frozen Section is a conventional method to check whether tumor margins are clear – all cancerous tissue was removed. However, intraoperative FS is subject to various limitations and errors leading to false-negative margins and failed oral surgery. Errors such as sampling error, technical error, interpretation error. Furthermore, it is a time and labor-consuming process, not always available in low-resource settings.
VELscan real-time assessment of surgical margin is cost and time saving, effective way to determine appropriate surgical margin with higher accuracy.
4. VELscope guided DNA Ploidy test and Biopsy
Increase diagnostic accuracy by selecting the most representative sampling area using VELscope.
Accurate and timely diagnosis of oral cancer is crucial for successful treatment. Although biopsy is a golden standard to confirm oral cancer diagnosis, it’s not always accurate. The most common reason is a sampling error. Data shows that 60% of diagnostic discordance with final pathology report of incisional biopsy in the oral cavity was attributed to sampling error when sampled tissue was not representative of the lesion.
VELscope guided biopsy– incisional and excisional helps to attain the appropriate site and improves the accuracy of diagnosis.
5. Painless Follow-up
Regular follow-up after an oral cancer surgery is crucial to prevent recurrence. However, painful biopsy scares patients and they often choose to risk they life and skip their appointment. Comprehensive VELscan examination using VELscope Vx together with non-invasive and painless DNA Ploidy test makes follow-up visit a pleasant experience that reduces the risk of recurrence even further and gives a patients peace of mind.
Case Reports - VELscope Guided Surgery
VELscope device is the world’s leading tool for enhanced oral cancer examinations. Also, it the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the surgical margin better.
VELscope Guided Oral Cancer Surgery
Determine appropriate surgical margin more accurately in a real-time and increase your patient survival rate reducing recurrence up to 90%
More accurate Surgical Margin in Real-TimeAssessment
VELscope Vx enhances the visibility of diseased tissue around a clinically-apparent lesion in real-time and helps to determine the appropriate surgical margin more accurately.
Result: Reduce oral cancer recurrence up to 90%
Instant Benefits for Doctors & Patients
- Reduce oral cancer recurrence up to 90%
- WHO recommended & FDA approved
- Real-time Assessment
- More effective than intraoperative FS
- Improved workflow – saved surgery time
- Evidence-based & Photo Documentation
- High success rate – satisfied patients
- Early diagnosis & Early treatment
- Painless follow-up
Dr. Pushkar P. Waknis From Operation Room
5 Reasons To Start Using VELscope Vx
1. Better oral cancer surgery outcomes
The tumor border is not clearly visible in white light to a naked eye. Sometimes it’s not apparent at all. Furthermore, diseased tissue often exceeds clinically apparent lesion and research have proved that oral cancer extension is not uniform around the cancerous area. So standard uniform margin around the tumor site may not always work causing not complete removal of cancerous cells. Such failure of a surgery may can cause cancer recurrence.
Meanwhile VELscope Guided Surgery enhances visibility of tumor border, so complete diseased tissue can be removed successfully. As a result, the risk of cancer coming back after surgery is reduced up to 90%.
2. Easy to use technology
The VELscope handheld device emits a harmless, bright blue light which enhances visualization of abnormal area, so tumor border can be seen clearly. Healthy tissue reflects blue light and appears as green, while diseased tissue absorbs blue light and appears dark, showing loss of fluorescence.
VELscope Vx is the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the appropriate margin for surgical excision.
3. More effective than Frozen Section (FS)
Intraoperative Frozen Section is a conventional method to check whether tumor margins are clear – all cancerous tissue was removed. However, intraoperative FS is subject to various limitations and errors leading to false-negative margins and failed oral surgery. Errors such as sampling error, technical error, interpretation error. Furthermore, it is a time and labor-consuming process, not always available in low-resource settings.
VELscan real-time assessment of surgical margin is cost and time saving, effective way to determine appropriate surgical margin with higher accuracy.
4. VELscope guided DNA Ploidy test and Biopsy
Increase diagnostic accuracy by selecting the most representative sampling area using VELscope.
Accurate and timely diagnosis of oral cancer is crucial for successful treatment. Although biopsy is a golden standard to confirm oral cancer diagnosis, it’s not always accurate. The most common reason is a sampling error. Data shows that 60% of diagnostic discordance with final pathology report of incisional biopsy in the oral cavity was attributed to sampling error when sampled tissue was not representative of the lesion.
VELscope guided biopsy– incisional and excisional helps to attain the appropriate site and improves the accuracy of diagnosis.
5. Painless Follow-up
Regular follow-up after an oral cancer surgery is crucial to prevent recurrence. However, painful biopsy scares patients and they often choose to risk they life and skip their appointment. Comprehensive VELscan examination using VELscope Vx together with non-invasive and painless DNA Ploidy test makes follow-up visit a pleasant experience that reduces the risk of recurrence even further and gives a patients peace of mind.
Case Reports
VELscope Guided Surgery
VELscope device is the world’s leading tool for enhanced oral cancer examinations. Also, it the first device approved by FDA and Health Canada to be used by surgeons to help identify diseased tissue around a clinically-apparent lesion and thus aid in determining the surgical margin better.